No Detail Found!

Comparison of efficacy and safety of topical betamethasone valerate 0.1% with narrowband-UVB in atopic dermatitis

Author(s)
Rajani Agrawal Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Bushra Bashir Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Sadia Qayuum Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Sara Inayat Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Khawar Khurshid Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Sabrina Suhail Pal Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Faria Altaf Department of Dermatology, Unit-II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Abstract
Objective To compare the efficacy and safety of topical betamethasone valerate 0.1% with narrowband ultraviolet B (NB-UVB) therapy in atopic dermatitis. Method Sixty patients with AD fulfilling the inclusion criteria were entered in the study. Patients were divided into 2 groups. Group A were given betamethasone valerate 0.1% twice a day for 4 weeks. Group B were given NB-UVB thrice a week for 8 weeks. Starting dose was 75% of minimal erythema dose (MED) for the skin type III and IV. Dose was increased by 20% on each visit as tolerated by the patients. During treatment patients were assessed at 2nd and 4th week for betamethasone valerate and 2nd, 4th, 6th and 8th week for NB-UVB. Results 84% patients in group A (betamethasone) showed >50% reduction in Scoring of Atopic Dermatitis (SCORAD) whereas 94% patients in group B (NB-UVB) showed >50% reduction in SCORAD (p=0.554). Side effects were seen in 34% patients in group A and 20% in group B. Conclusion Both betamethasone valerate 0.1% and NB-UVB are almost equal in terms of efficacy but NB-UVB is more safe than betamethasone valerate 0.1%.
Publication Details
Page(s) 239-244
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 28, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
Safety, Atopic dermatitis, efficacy, betamethasone Valerate 0, NB-UVB
0

Citations

0

Downloads

63

Views